Contents
|
|
|
OVERVIEW
GRADE
II AND GRADE III GLIOMAS
EXTERNAL
SECTIONS
■
RADIOTHERAPY
|
|
|
Overview
|
▲
|
.
|
Alkins RD, Mainprize TG.
High-Intensity Focused
Ultrasound Ablation Therapy of Gliomas
Prog Neurol Surg.
Basel, Karger, 2018, vol 32, pp 39-47 (DOI:10.1159/000469678).
Published online: July 10, 2018.
Source
| Full
text
|
|
|
.
|
Butowski N.
Novel and Prospective Molecular Targets for
Therapy of Intracranial Gliomas
Prog Neurol Surg. Basel,
Karger, 2018, vol 32, pp 66-78 (DOI:10.1159/000469681). Published
online: July 10, 2018.
Source
| Full
text
|
|
|
.
|
Combs SE.
Proton and Carbon Ion Therapy of Intracranial
Gliomas
Prog Neurol Surg. Basel, Karger, 2018, vol 32,
pp 57-65 (DOI:10.1159/000469680). Published online: July 10, 2018.
Source
| Full
text
|
|
|
.
|
Goldbrunner R, Ruge M, Kocher M, Lucas CW, Galldiks N, Grau S.
The Treatment of Gliomas in Adulthood.
Dtsch
Arztebl Int. 2018 May 21;115(20-21):356-364. doi:
10.3238/arztebl.2018.0356.
Source
|
Abstract
| Full
text |
Similar
articles
|
|
|
.
|
Ho ALK, Jena R.
Re-irradiation in the Brain: Primary
Gliomas.
Clin Oncol (R Coll Radiol). 2018
Feb;30(2):124-136. doi: 10.1016/j.clon.2017.11.006.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Iwami K, Natsume A, Wakabayashi T.
Cytokine Therapy of
Gliomas
Prog Neurol Surg. Basel, Karger, 2018, vol 32,
pp 79-89 (DOI:10.1159/000469682). Published online: July 10, 2018.
Source
| Full
text
|
|
|
.
|
Kaneko S, Fujimoto S, Yamaguchi H, Yamauchi T, Yoshimoto T, Tokuda
K.
Photodynamic Therapy of Malignant Gliomas
Prog
Neurol Surg. Basel, Karger, 2018, vol 32, pp 1-13.
(DOI:10.1159/000469675). Published online: July 10, 2018.
Source
| Full
text
|
|
|
.
|
Karampelas I, Sloan A.E.
Laser-Induced Interstitial
Thermotherapy of Gliomas
Prog Neurol Surg. Basel,
Karger, 2018, vol 32, pp 14-26 (DOI:10.1159/000469676). Published
online: July 10, 2018.
Source
| Full
text
|
|
|
.
|
Kim JW, Chang AL, Kane JR, Young JS, Qiao J, Lesniak MS.
Gene
Therapy and Virotherapy of Gliomas
Prog Neurol Surg.
Basel, Karger, 2018, vol 32, pp 112-123 (DOI:10.1159/000469685).
Published online: July 10, 2018.
Source
| Full
text
|
|
|
|
Li
G, Qin Z, Chen Z, Xie L, Wang R, Zhao H.
Tumor
Microenvironment in Treatment of Glioma.
Open
Med (Wars). 2017 Aug 12;12:247-251. doi: 10.1515/med-2017-0035.
eCollection 2017.
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
.
|
Martynov BV, Kholyavin AI, Nizkovolos VB, Parfenov VE, Trufanov
GE, Svistov DV.
Stereotactic Cryodestruction of Gliomas
Prog Neurol Surg. Basel, Karger, 2018, vol 32, pp 27-38
(DOI:10.1159/000469677). Published online: July 10, 2018.
Source
| Full
text
|
|
|
.
|
Parker Kerrigan BC, Hossain A, Yamashita S, Lang FF.
Stem
Cell Therapy of Gliomas
Prog Neurol Surg. Basel, Karger,
2018, vol 32, pp 124-151 (DOI:10.1159/000469686). Published
online: July 10, 2018.
Source
| Full
text
|
|
|
.
|
Santiago-Dieppa DR, Gonda DD, Cheung VJ, Steinberg JA, Carter BS,
Chen CC.
Extracellular Vesicles as a Platform for Glioma
Therapeutic Development
Prog Neurol Surg. Basel, Karger,
2018, vol 32, pp 172-179 (DOI:10.1159/000469689). Published
online: July 10, 2018.
Source
| Full
text
|
|
|
|
Uhm
JH, Porter AB.
Treatment
of Glioma in the 21st Century: An Exciting Decade of Postsurgical
Treatment Advances in the Molecular Era.
Mayo
Clin Proc. 2017 Jun;92(6):995-1004. doi:
10.1016/j.mayocp.2017.01.010
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
IMMUNOTHERAPY
|
|
|
Aquino
D, Gioppo A, Finocchiaro G, Bruzzone MG, Cuccarini V.
MRI
in Glioma Immunotherapy: Evidence, Pitfalls, and Perspectives.
J
Immunol Res. 2017;2017:5813951. doi: 10.1155/2017/5813951. Epub
2017 Apr 20.
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
.
|
Eissa IR, Bustos-Villalobos I, Ichinose T, Matsumura S, Naoe Y,
Miyajima N, Morimoto D, Mukoyama N, Zhiwen W, Tanaka M, Hasegawa
H, Sumigama S, Aleksic B, Kodera Y, Kasuya H.
The Current
Status and Future Prospects of Oncolytic Viruses in Clinical
Trials against Melanoma, Glioma, Pancreatic, and Breast Cancers.
Cancers (Basel). 2018 Sep 26;10(10). pii: E356. doi:
10.3390/cancers10100356.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Everson RG, Antonios JP, Liau L.M.
Cell-Based
Immunotherapy of Gliomas
Prog Neurol Surg. Basel,
Karger, 2018, vol 32, pp 90-100 (DOI:10.1159/000469683). Published
online: July 10, 2018.
Source
| Full
text
|
|
|
.
|
Platten M, Reardon DA.
Concepts for Immunotherapies in
Gliomas.
Semin Neurol. 2018 Feb;38(1):62-72. doi:
10.1055/s-0037-1620274. Epub 2018 Mar 16.
Source
|
Abstract
| Full
text |
Similar
articles
|
|
|
|
Platten
M, Bunse L, Wick W, Bunse T.
Concepts
in glioma immunotherapy.
Cancer
Immunol Immunother. 2016 Jul 26. [Epub ahead of print]
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
.
|
Hanaei S, Afshari K, Hirbod-Mobarakeh A, Mohajer B, Amir
Dastmalchi D, Rezaei N.
Therapeutic efficacy of specific
immunotherapy for glioma: a systematic review and meta-analysis.
Rev Neurosci. 2018 Jun 27;29(4):443-461. doi:
10.1515/revneuro-2017-0057.
Source
| Full
text | Similar
articles
|
|
|
.
|
Weant MP, Jesús
CM, Yerram P.
Immunotherapy in Gliomas.
Semin
Oncol Nurs. 2018 Dec;34(5):501-512. doi:
10.1016/j.soncn.2018.10.011. Epub 2018 Nov 2.
Source
| Full
text |
Similar
articles
|
|
|
ANTINEOPLASTIC
EFFECTS OF ANTIEPILEPTIC DRUGS
|
|
.
|
Li Z, Xia Y, Bu X, Yang D, Yuan Y, Guo X, Zhang G, Wang Z, Jiao J.
Effects of valproic acid on the susceptibility of human
glioma stem cells for TMZ and ACNU.
Oncol Lett. 2018
Jun;15(6):9877-9883. doi: 10.3892/ol.2018.8551. Epub 2018 Apr 20.
Source
|
Abstract
| Full
text |
Similar
articles
|
|
|
|
Rizzo
A, Donzelli S, Girgenti V, Sacconi A, Vasco C, Salmaggi A,
Blandino G, Maschio M, Ciusani E.
In
vitro antineoplastic effects of brivaracetam and lacosamide on
human glioma cells.
J
Exp Clin Cancer Res. 2017 Jun 6;36(1):76. doi:
10.1186/s13046-017-0546-9.
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
BRAIN
PENETRANCE OF ANTICANCER DRUGS
|
|
.
|
Levin VA, Ellingson BM.
Understanding Brain Penetrance of
Anticancer Drugs.
Neuro Oncol. 2018 Feb 21. doi:
10.1093/neuonc/noy018. [Epub ahead of print]
Source
|
Abstract
| Full
text |
Similar
articles
|
|
|
CHEMOTHERAPY
|
|
|
|
MITOXANTRONE
|
|
|
Ellis
JA, Cooke J, Singh-Moon RP, Wang M, Bruce JN, Emala CW, Bigio IJ,
Joshi S.
Safety,
feasibility, and optimization of intra-arterial mitoxantrone
delivery to gliomas.
J
Neurooncol. 2016 Dec;130(3):449-454. Epub 2016 Aug 30.
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
TEMOZOLOMIDE
|
|
|
|
Temodex
|
|
.
|
Karlsson I, Veevnik D, Fedulov A, Yurkshtovich N, Yurkshtovich T,
Pejler G, Lokot I.
Local delivery of temozolomide via a
biologically inert carrier (Temodex) prolongs survival of glioma
patients irrespectively of the MGMT methylation status.
Neoplasma. 2018 Dec 12. pii: 180613N393. doi:
10.4149/neo_2018_180613N393. [Epub
ahead of print]
Source
| Full
text | Similar
articles
|
|
|
HIPPOCAMPUS
|
|
|
Karunamuni
RA, Seibert TM, White NS, McEvoy L, Farid N, Brewer J, Dale AM,
McDonald CR, Hattangadi-Gluth JA.
Abnormalities
in hippocampal volume of glioma patients prior to radiotherapy.
Acta
Oncol. 2017 Mar;56(3):427-430. doi: 10.1080/0284186X.2017.1280847.
Epub 2017 Feb 3.
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
INTRANASAL
DRUG DELIVERY
|
|
.
|
Fan Y, Chen M, Zhang J, Maincent P, Xia X, Wu W.
Updated
Progress of Nanocarrier-Based Intranasal Drug Delivery Systems for
Treatment of Brain Diseases.
Crit Rev Ther Drug Carrier
Syst. 2018;35(5):433-467. doi:
10.1615/CritRevTherDrugCarrierSyst.2018024697.
Source
|
Abstract
| Similar
articles
|
|
|
MGMT
|
|
|
Li
Q, Guo J, Wang W, Wang D.
Relationship
between MGMT gene expression and treatment effectiveness and
prognosis in glioma.
Oncol
Lett. 2017 Jul;14(1):229-233. doi: 10.3892/ol.2017.6123. Epub 2017
May 5.
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
NERVE
GROWTH FACTOR
|
|
|
Falsini
B, Chiaretti A, Rizzo D, Piccardi M, Ruggiero A, Manni L, Soligo
M, Dickmann A, Federici M, Salerni A, Timelli L, Guglielmi G,
Lazzareschi I, Caldarelli M, Galli-Resta L, Colosimo C, Riccardi
R.
Nerve
growth factor improves visual loss in childhood optic gliomas: a
randomized, double-blind, phase II clinical trial.
Brain.
2016 Feb;139(Pt 2):404-14. doi: 10.1093/brain/awv366. Epub 2016
Jan 14.
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
SURGERY
|
|
|
Sanai N, Berger MS.
Surgical oncology for gliomas: the
state of the art.
Nat Rev Clin Oncol. 2017 Nov 21. doi:
10.1038/nrclinonc.2017.171. [Epub ahead of print]
Source
|
Abstract
| Full
text |
Similar
articles
|
|
|
|
Southwell DG, Birk HS, Han SJ, Li J, Sall JW, Berger MS.
Resection of gliomas deemed inoperable by neurosurgeons
based on preoperative imaging studies.
J Neurosurg. 2017
Nov 10:1-9. doi: 10.3171/2017.5.JNS17166. [Epub ahead of print]
Source
|
Abstract
| Full
text |
Similar
articles
|
|
|
INTRA-OPERATIVE
IMAGING
|
|
|
Caras A, Mugge L, Miller WK, Mansour TR, Schroeder J, Medkour A.
Utility and impact of intra-operative imaging for glioma
resection on patient outcome and extent of resection: A systematic
review and meta-analysis.
World Neurosurg. 2019 Oct 19.
doi: 10.1016/j.wneu.2019.10.072. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
SUPRATOTAL
RESECTION
|
|
.
|
de Leeuw CN, Vogelbaum MA.
Supratotal Resection in
Glioma: A Systematic Review.
Neuro Oncol. 2018 Oct 15.
doi: 10.1093/neuonc/noy166. [Epub ahead of print]
Source
| Full
text |
Similar
articles
|
|
|
VENOUS
THROMBOEMBOLISM
|
|
|
Al
Megren M, De Wit C, Al Qahtani M, Le Gal G, Carrier M.
Management
of venous thromboembolism in patients with glioma.
Thromb
Res. 2017 Jun 8;156:105-108. doi: 10.1016/j.thromres.2017.06.010.
[Epub ahead of print]
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
Laboratory
investigations
|
|
|
|
RADIOTHERAPY
|
|
|
|
OVERCOMING
RADIORESISTANCE BY ERADICATING STEM CELLS
|
|
.
|
Chiblak S, Tang Z, Lemke D, Knoll M, Dokic I, Warta R, Moustafa M,
Mier W, Brons S, Rapp C, Muschal S, Seidel P, Bendzsus M, Adeberg
S, Wiestler OD, Haberkorn U, Debus J, Herold-Mende C, Wick W,
Abdollahi A.
Carbon irradiation overcomes glioma
radioresistance by eradicating stem cells and forming an
antiangiogenic and immunopermissive niche.
JCI Insight.
2019 Jan 24;4(2). pii: 123837. doi: 10.1172/jci.insight.123837.
[Epub ahead of print]
Source
| Full
text | Similar
articles
|
|
|
VALPROIC
ACID
|
|
.
|
Riva G, Cilibrasi C, Bazzoni R, Cadamuro M, Negroni C, Butta V,
Strazzabosco M, Dalprà L, Lavitrano M, Bentivegna A.
Valproic Acid Inhibits Proliferation and Reduces
Invasiveness in Glioma Stem Cells Through Wnt/β Catenin
Signalling Activation.
Genes (Basel). 2018 Oct 26;9(11).
pii: E522. doi: 10.3390/genes9110522.
Source
| Full
text |
Similar
articles
|
|
|
Clinical
investigations
|
|
|
|
RADIATION
THERAPY
|
|
.
|
Jhaveri J, Cheng E, Tian S, Buchwald Z, Chowdhary M, Liu Y,
Gillespie TW, Olson JJ, Diaz AZ, Voloschin A, Eaton BR, Crocker
IR, McDonald MW, Curran WJ, Patel KR.
Proton vs. Photon
Radiation Therapy for Primary Gliomas: An Analysis of the National
Cancer Data Base.
Front Oncol. 2018 Nov 28;8:440. doi:
10.3389/fonc.2018.00440. eCollection
2018.
Source
| Full
text | Similar
articles
|
|
|
Recurrent
tumors
|
|
|
|
INTRANASAL
THERAPY
|
|
.
|
Chen TC, da Fonseca CO, Schönthal AH.
Intranasal
Perillyl Alcohol for Glioma Therapy: Molecular Mechanisms and
Clinical Development.
Int J Mol Sci. 2018 Dec 6;19(12).
pii: E3905. doi: 10.3390/ijms19123905.
Source
|
Similar
articles
|
|
|
RE-IRRADIATION
|
|
|
Krauze A, Attia A, Braunstein S, Chan M, Combs S, Fietkau R,
Fiveash J, Flickinger J, Grosu A, Howard S, Nieder C, Niyazi M,
Rowe L, Smart DD, Tsien C, Camphausen K.
Expert consensus
on re-irradiation for recurrent glioma.
Radiat Oncol.
2017 Dec 1;12(1):194. doi: 10.1186/s13014-017-0928-3.
Source
|
Abstract
| Full
text |
Similar
articles
|
|
|
.
|
Post CCB, Kramer MCA, Smid EJ, van der Weide HL, Kleynen CE,
Heesters MAAM, Verhoeff JJC.
Patterns of re-irradiation
for recurrent gliomas and validation of a prognostic score.
Radiother Oncol. 2018 Nov 13. pii: S0167-8140(18)33575-8.
doi: 10.1016/j.radonc.2018.10.034. [Epub ahead of print]
Source
| Full
text |
Similar
articles
|
|
|
RE-IRRADIATION
AFTER SECOND SURGERY
|
|
.
|
Combs SE, Kessel KA, Hesse J, Straube C, Zimmer C, Schmidt-Graf F,
Schlegel J, Gempt J, Meyer B.
Moving Second Courses of
Radiotherapy Forward: Early Re-Irradiation After Surgical
Resection for Recurrent Gliomas Improves Efficacy With Excellent
Tolerability.
Neurosurgery. 2018 Feb 16. doi:
10.1093/neuros/nyx629. [Epub ahead of print]
Source
|
Abstract
| Full
text |
Similar
articles
|
|
|
RADIOSURGERY
|
|
.
|
Sadik ZHA, Hanssens PEJ, Verheul JB, Beute GN, Te Lie S, Leenstra
S, Ardon H.
Gamma knife radiosurgery for recurrent
gliomas.
J Neurooncol. 2018 Sep 6. doi:
10.1007/s11060-018-2988-0. [Epub ahead of print]
Source
| Full
text |
Similar
articles
|
|
|
TOCA
511
|
|
|
[No authors listed]
Treating Recurrent Glioma with Toca
511.
Cancer
Discov. 2017 Nov 8. doi: 10.1158/2159-8290.CD-NB2017-157. [Epub
ahead of print]
Source
|
Abstract
| Full
text |
Similar
articles
|
|
|
Grade
II and grade III gliomas
|
|
.
|
Lin AJ, Campian JL, Hui C, Rudra S, Rao YJ, Thotala D, Hallahan D,
Huang J.
Impact of concurrent versus adjuvant
chemotherapy on the severity and duration of lymphopenia in glioma
patients treated with radiation therapy.
J Neurooncol.
2017 Nov 16. doi: 10.1007/s11060-017-2668-5. [Epub ahead of print]
Source
| Full
text |
Similar
articles
|
|
|
.
|
Picca A, Berzero G, Sanson M.
Current therapeutic
approaches to diffuse grade II and III gliomas.
Ther Adv
Neurol Disord. 2018 Jan 17;11:1756285617752039. doi:
10.1177/1756285617752039. eCollection 2018.
Source
| Full
text |
Similar
articles
|
|
|
.
|
van den Bent MJ, Klein M, Smits M, Reijneveld JC, French PJ,
Clement P, de Vos FYF, Wick A, Mulholland PJ, Taphoorn MJB, Lewis
J, Weller M, Chinot OL, Kros JM, de Heer I, Verschuere T, Coens C,
Golfinopoulos V, Gorlia T, Idbaih A.
Bevacizumab and
temozolomide in patients with first recurrence of WHO grade II and
III glioma, without 1p/19q co-deletion (TAVAREC): a randomised
controlled phase 2 EORTC trial.
Lancet Oncol. 2018 Aug
13. pii: S1470-2045(18)30362-0. doi:
10.1016/S1470-2045(18)30362-0. [Epub ahead of print]
Source
| Full
text |
Similar
articles
|
|
|
.
|
Wood H.
Addition of bevacizumab fails to improve on
temozolomide alone for glioma therapy.
Nat Rev
Neurol. 2018 Aug 29. doi: 10.1038/s41582-018-0067-y. [Epub ahead
of print]
Comment
on: Van den Bent MJ et al.,Bevacizumab and temozolomide in
patients with first recurrence of WHO grade II and III glioma,
without 1p/19q co-deletion (TAVAREC): a randomised controlled
phase 2 EORTC trial. [Lancet Oncol. 2018 Aug 13].
Source
| Full
text |
Similar
articles
|
|
|
|
|
|
▲
|